The global urodynamic equipment market was valued at USD 217.7 million in 2016, and is anticipated to grow at a CAGR of 6.7% throughout the forecast period. The market is predominantly driven by rising prevalence of diseases such as benign prostatic hypertrophy, bladder cancer, neurogenic bladder dysfunction, overactive bladder, and others.
According to World Health Organization, globally, 330,000 new cases of bladder cancer are diagnosed every year. Moreover, as per National Association for Incontinence, 200 million people globally are suffering from urinary incontinence, which raises the clinical urgency to adopt urodynamic equipment.
North America accounted for the largest share of over 30% amongst all regions in urodynamic equipment market in 2017. This can be attributed to rising prevalence of target diseases. The dominant share is also a consequence of high adoption rate of urodynamic products in various diagnostic, healthcare, & pharmaceutical centers and growing preference of urologist and gynaecologists & urologists for urodynamic tests.
Asia is expected to witness exponential CAGR of over 7.0% throughout the forecast period. This growth can be attributed to rise in prevalence of urological diseases, growing disposable income, and unmet patient needs. Rapid rise in geriatric population, which has greater vulnerability to urological dysfunctions, is expected to further contribute to the market growth across this region.
Another factor expected to contribute to growth in Asia is increasing availability and usage in diagnostic centers. In addition, rapid economic growth in developing countries such as India, Singapore, China, and others is also anticipated to boost product penetration.
Prominent players in the urodynamic equipment market are Covidien plc, C. R. Bard, Inc., Albyn Medical S.L., American Medical Systems, Inc., CooperSurgical, Inc., HealthTronics, Inc., LABORIE, Medical Measurement Systems B.V. and Verathon, Inc.
This research report covers the global urodynamic equipment market by type; end user; and geography.
Table of Contents
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Study
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Crackdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data Points Taken From Secondary Sources
2.3.2 Key Data Points Taken From Primary Sources
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
6 Urodynamic Equipment Market, By Type
6.2 Urodynamic Equipment
6.2.1 Uroflowmetry Equipment
6.2.3 Ambulatory Urodynamic Systems
6.2.5 Video Urodynamic Systems
6.3 Urodynamic Consumables
6.3.1 Urodynamic Catheters
6.3.2 Urodynamic Pumps and Transducer Sets
7 Urodynamic Equipment Market, By Application
7.2 Kidney Diseases
7.4 Other Applications
8 Urodynamic Equipment Market, By End User
8.2 Hospitals & Urology Clinics
8.3 Ambulatory Centers
8.4 Other End Users
9 Urodynamic Equipment Market, By Region
9.2 North America
9.3.4 Rest of Europe
9.4.4 Rest of Asia
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
11 Company Profiles*
11.2 Covidien PLC.
10.2.1 Business Overview
10.2.2 Company Financials
10.2.3 Recent Developments
10.2.4 Product & Service Offerings
10.2.5 MnM View
11.3 C. R. Bard, Inc.
11.4 Albyn Medical S.L.
11.5 American Medical Systems Inc.
11.6 Coopersurgical, Inc.
11.7 Healthtronics, Inc.
11.9 Medical Measurement Systems B.V.
11.10 Verathon, Inc.
Note: *Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
* 10 to 15 Market Leaders Will Be Profiled
* Segmentation May Change During the Planned Research Work
Benchmarking the rapid strategy shifts of the Top 100 companies in the Urodynamic Equipment MarketRequest For Special Pricing